Fukoku Mutual Life Insurance’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Sell |
659
-255
| -28% | -$83.2K | 0.01% | 251 |
|
|
2025
Q1 | $247K | Hold |
914
| – | – | 0.02% | 228 |
|
|
2024
Q4 | $215K | Hold |
914
| – | – | 0.02% | 256 |
|
|
2024
Q3 | $251K | Hold |
914
| – | – | 0.02% | 241 |
|
|
2024
Q2 | $222K | Buy |
+914
| New | +$222K | 0.02% | 251 |
|
|
2023
Q1 | – | Sell |
-1,430
| Closed | -$340K | – | 257 |
|
|
2022
Q4 | $340K | Hold |
1,430
| – | – | 0.03% | 176 |
|
|
2022
Q3 | $286K | Sell |
1,430
-150
| -9% | -$30K | 0.03% | 204 |
|
|
2022
Q2 | $230K | Hold |
1,580
| – | – | 0.02% | 241 |
|
|
2022
Q1 | $258K | Hold |
1,580
| – | – | 0.02% | 249 |
|
|
2021
Q4 | $268K | Buy |
1,580
+50
| +3% | +$8.48K | 0.02% | 244 |
|
|
2021
Q3 | $289K | Buy |
1,530
+230
| +18% | +$43.4K | 0.02% | 238 |
|
|
2021
Q2 | $220K | Hold |
1,300
| – | – | 0.02% | 259 |
|
|
2021
Q1 | $184K | Hold |
1,300
| – | – | 0.02% | 256 |
|
|
2020
Q4 | $169K | Hold |
1,300
| – | – | 0.02% | 259 |
|
|
2020
Q3 | $189K | Buy |
1,300
+200
| +18% | +$29.1K | 0.02% | 232 |
|
|
2020
Q2 | $163K | Hold |
1,100
| – | – | 0.02% | 235 |
|
|
2020
Q1 | $120K | Hold |
1,100
| – | – | 0.02% | 233 |
|
|
2019
Q4 | $127K | Buy |
1,100
+300
| +38% | +$34.6K | 0.01% | 275 |
|
|
2019
Q3 | $64K | Hold |
800
| – | – | 0.01% | 298 |
|
|
2019
Q2 | $58K | Buy |
800
+100
| +14% | +$7.25K | 0.01% | 301 |
|
|
2019
Q1 | $65K | Hold |
700
| – | – | 0.01% | 285 |
|
|
2018
Q4 | $51K | Buy |
700
+200
| +40% | +$14.6K | 0.01% | 294 |
|
|
2018
Q3 | $44K | Hold |
500
| – | – | 0.01% | 305 |
|
|
2018
Q2 | $49K | Buy |
500
+100
| +25% | +$9.8K | 0.01% | 297 |
|
|
2018
Q1 | $48K | Hold |
400
| – | – | 0.01% | 292 |
|
|
2017
Q4 | $51K | Buy |
+400
| New | +$51K | 0.01% | 286 |
|